India, April 13 -- Fastenal Company (FAST) shares declined 6.55 percent to $45.95, down $3.22 on Monday, even as the company reported higher first-quarter earnings compared to the same period last yea... Read More
India, April 13 -- The New Zealand dollar weakened against other major currencies in the Asian session on Monday. The NZ dollar fell to 5-day lows of 0.5801 against the U.S. dollar and 2.0121 against... Read More
India, April 13 -- Satellite Chemical Co.,Ltd. (002648.SZ) announced a profit for its first quarter that Increased, from the same period last year The company's bottom line totaled RMB2.117 billion, ... Read More
India, April 13 -- Indian shares tumbled on Monday as the failure of U.S.-Iran negotiations heightened concerns of a prolonged conflict in the Middle East. Adding to investor anxiety, U.S. President ... Read More
India, April 13 -- The Australian dollar weakened against other major currencies in the Asian session on Monday. The Australian dollar fell to 5-day lows of 0.7017 against the U.S. dollar and 1.6638 ... Read More
India, April 12 -- Telix Pharmaceuticals Limited (TLX,TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation radiopharma... Read More
India, April 12 -- Nova Minerals Limited (NVA,NVA.AX) announced the appointment of Ashlie Thorburn as Chief Financial Officer (CFO), commencing 20 April 2026. Thorburn has more than 20 years experien... Read More
India, April 12 -- AbbVie (ABBV) reported promising results from the Phase 2 IMGN853-0420 trial evaluating mirvetuximab soravtansine-gynx (ELAHERE) in combination with carboplatin, followed by mirvetu... Read More
India, April 12 -- Indian shares are seen opening notably lower on Monday as U.S.-Iran peace talks collapsed amid unresolved disputes over Iran's nuclear program, and U.S. President Donald Trump order... Read More
India, April 12 -- GSK plc (GSK,GSK.L) announced encouraging findings from its global phase I BEHOLD-1 clinical trial for mocertatug rezetecan (Mo-Rez), a novel antibody-drug conjugate (ADC) targeting... Read More